Essex Woodlands Management, Inc.

Est. AUM

$250.54B

13F long equity, this entity only

Positions

Period

Mar 2026 (Q1)

SEC EDGAR

Mar 2026 (Q1)

#	Issuer	Class	Value	Shares	% Portfolio	Discretion
1	BIOVENTUS INC	COM CL A	$118.88B	13021324	47.45%	SOLE
2	MIMEDX GROUP INC	COM	$111.37B	28195249	44.45%	SOLE
3	EYEPOINT PHARMACEUTICALS INC	COM NEW	$13.98B	1084857	5.58%	SOLE
4	TELA BIO INC	COM	$4.78B	7714709	1.91%	SOLE
5	MEDICINOVA INC	COM NEW	$1.52B	1105941	0.60%	SOLE

Values in USD (reported in $thousands on 13F). Source: SEC EDGAR.